Varshavski: I asked a bunch of different specialists what's the one medical breakthrough they're excited about in their ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

For columnist Alyssa Silva, advances in the development of SMA treatments have felt like glimmers of miracles.

How mission plus performance can lead to sustainable success.

Two former CEOs were recently convicted for their roles in a scheme to lie to investors in a publicly traded biotechnology company, CytoDyn Inc. Nader Pourhassan and Kazem Kazempour together engaged ...

January 2025 – Marinomed Biotech AG (VSE:MARI) announces that CFO Pascal Schmidt is leaving the Company as of January 31 st, 2025. Gabriele Ram will be taking over the administration of the financial ...

Avec Les Echos suivez en temps réel toute l'actualité financière puisée aux meilleures sources des sociétés cotées sur les bourses de Paris, Bruxelles, Amsterdam, Lisbonne, Francfort et New York.

31.01.2025 / 12:10 CET/CEST The issuer is solely responsible for the content of this announcement. Marinomed Biotech AG: Changes to the Management Board CFO Pascal Schmidt is resigning at the end ...

CFO Pascal Schmidt is resigning at the end of January 2025 Gabriele Ram, former Wienerberger AG, takes over the management of the finance department on an interim basis Restructuring proceedings ...

EQS-News: Marinomed Biotech AG / Key word(s): Personnel Marinomed Biotech AG: Changes to the Management Board 31.01.2025 / 12:10 CET/CEST The issuer is solely responsible for the content of this ...